Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
insulin
2
×
life sciences
2019
activism
acute hepatic porphyria
alnylam pharmaceuticals
bernie sanders
bioinnovation capital
biolabs
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
buyout
celgene
charges
chemotherapy
congress
crisis
daraprim
detroit blog main
detroit top stories
drug prices
drug pricing
drugs
easl
epipen
epipens
exome
fatty liver disease
gene therapy
generic drugs
givosiran
house of representatives
indiana blog main
indiana top stories
indivior
What
drug
2
×
advanced
alnylam’s
approval
bff
bio
biotech
conference
deals
devoted
disease
driving
easl
form
gene
good
healthcare
history
improved
industry
innovation
innovations
investment
kicked
life
liver
long
major
medical
outcomes
pricing
proud
public
race
roundup
sciences
therapy
treat
updates
wide
Language
unset
Current search:
insulin
×
drug
×
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
